Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 30, 2012

Leading Global Multiple Sclerosis Research Center Taps IBM Analytics to Improve Patient Care

  • MS Research Study and Reports
    /
Insights From Big Data Aimed At Slowing Progression of Multiple Sclerosis By IBM Published: Thursday, Apr. 26, 2012 – 6:12 am…
MS Research Study and Reports

April 30, 2012

Tysabri Seems OK for Expectant Mothers with MS

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
By Ed Susman, Contributing Writer, MedPage Today Published: April 29, 2012 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of…
MS Research Study and Reports

April 28, 2012

The younger a woman is diagnosed with MS, the greater chance she has of going 2 or more decades without significant progression

  • MS Research Study and Reports
    /
  • MS Views and News
    /
Slow MS Progress Most Likely if Diagnosed Young This report is part of a 12-month Clinical Context series. By Ed Susman,…
MS Research Study and Reports

April 28, 2012

Menopause Impact Negligible in MS

  • MS Research Study and Reports
    /
By Ed Susman, Contributing Writer, MedPage Today Published: April 27, 2012 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of…
MS Research Study and Reports

April 28, 2012

The Latest Research is in, on combination therapy with both Copaxone and Interferon

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
MS Drug Combo No Better than Each One Alone By John Gever, Senior Editor, MedPage Today Published: April 27, 2012 Reviewed by Robert…
MS Drug Therapies

April 28, 2012

New TYSABRI Data Presented at 64th Annual AAN Meeting Highlight Biogen Idec & Elan Commitment to Improving Outcomes in Multiple Sclerosis

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
Published April 27, 2012 Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced findings from several studies of TYSABRI® (natalizumab)…
MS Drug Therapies

April 28, 2012

Protein block `could halt multiple sclerosis`

  • MS Research Study and Reports
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
Washington: Scientists claim to have discovered that the progress of debilitating disease multiple sclerosis could be slowed or even stopped…
MS Research Study and Reports

April 27, 2012

Ann Romney Recounts MS Symptoms That Could Limit Her Campaign Trail Time

  • An MS Patients Story
    /
ABC News –  By Shushannah Walshe As general election campaigning begins in earnest, Ann Romney recounted a recent health scare and detailed the…
An MS Patients Story

April 27, 2012

Patients Drop MS Drug (Tysabri), Face Relapse Risk

  • MS Drug Therapies
    /
  • MS Views and News
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
This report is part of a 12-month Clinical Context series. By John Gever, Senior Editor, MedPage Today Published: April 25, 2012…
MS Drug Therapies

April 27, 2012

CONFIRM: Second Positive Trial for BG-12 in MS

  • MS Drug Therapies
    /
April 26, 2012 (New Orleans, Louisiana) — Full results of a second phase 3 trial of oral BG-12 (dimethyl fumarate,…
MS Drug Therapies

Categories

Latest Blog Posts